30 Most Obese Countries In The World in 2018: Biggest Anti-Obesity Drug Markets
The 30 most obese countries in the world in 2018 represent a huge (pun intended) market opportunity for weight loss drugmakers.
Posts Tagged ‘NASDAQ:OREX’
7 Over-the-Counter Diet Pills that Work Without Exercise
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
7 Most Popular Diet Pills That Work Fast Without Exercise
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
10 Best Performing Weight Loss Companies And Their Programs
The 10 best performing weight loss companies have found success in an increasingly competitive environment, one which is pitting supplement providers, medical device makers, weight...
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.
Most Popular Healthcare Penny Stocks Among Hedge Funds
Although a great movie, The Wolf of Wall Street left many people thinking penny stocks are somewhat 'untouchable'.
Five Penny Stocks To Buy Based on Smart Money Sentiment
No doubt, penny stocks are for investors with a greater than average risk appetite, but considering their inexpensiveness and the possibility of towering returns, if any of these...
What Do Hedge Funds Think of Orexigen Therapeutics, Inc. (OREX)?
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the government.
These Five Biotech Stocks Ranked Among This UK-based Fund’s Favorites
Cheyne Capital is one of the few non-U.S firms that we track in our database.
Orexigen Therapeutics Inc. (OREX) and Spectranetics Corp (SPNC): Billionaires Klarman and Cohen Snapped Up These Healthcare Stocks
Seth Klarman’s Baupost Group has initiated a new passive stake in Orexigen Therapeutics Inc. (NASDAQ:OREX), a new filing the U.S. Securities and Exchange Commission showed.
5 Healthcare Stocks Under $10 Ready To Pop
Investing in the healthcare sector can be tricky, especially if you're looking for high returns and want to invest in clinical-stage companies, which represent an above-average...
You Should Follow Hedge Funds Into One Semiconductor and One Healthcare Stock
In the first hours of trading, the markets showed slight signs of improvement, impacted by positive jobless claims data.
Foresite Capital Betting It All On These Four Healthcare Stocks
Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing the long positions held...
Five Hedge Fund Moves in Healthcare Sector From This Week
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow.
Partner Fund Management Ups Stake in Orexigen Therapeutics, Inc. (OREX)
Christopher Medlock James', San Francisco-based, hedge fund Partner Fund Management has raised its position in Orexigen Therapeutics, Inc.
Arena Pharmaceuticals, Inc. (ARNA): Are Investors Worried?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued a press release pointing out that its marketing partner Eisai had started direct-to-consumer advertising for their obesity drug...
Here is What Hedge Funds Think About Dynavax Technologies Corporation (DVAX)
If you were to ask many market players, hedge funds are seen as useless, outdated financial vehicles of a forgotten age.
Arena Pharmaceuticals, Inc. (ARNA), Orexigen Therapeutics, Inc. (OREX): VIVUS, Inc. (VVUS) Gets 3 CEOs in Less Than Two Months
The first guy, Leland Wilson, got kicked out. Never mind that he founded the company, Samuel Colin, senior managing partner at First Manhattan, VIVUS, Inc.
Should You Avoid Orexigen Therapeutics, Inc. (OREX)?
In the financial world, there are a multitude of metrics shareholders can use to watch their holdings.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Third Obesity Drug Moves Closer to FDA Approval
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s Belviq, VIVUS, Inc. (NASDAQ:VVUS)'s Qsymia, and Orexigen Therapeutics, Inc. (NASDAQ:OREX)'s Contrave were rejected by the Food and...
Hedge Funds Aren’t Crazy About Amarin Corporation plc (ADR) (AMRN) Anymore
In the financial world, there are many metrics shareholders can use to track their holdings. A duo of the most innovative are hedge fund and insider trading movement.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA), Orexigen Therapeutics, Inc. (OREX): Who Will Be the Winner in the Fight Against Obesity?
The obesity segment of the health care industry is turning into a battleground. VIVUS, Inc.
MannKind Corporation (MNKD), Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS) – Attention Biotech Investors: Stop Looking at Share Price
After my article on MannKind Corporation (NASDAQ:MNKD) earlier this week, a reader wasn't too happy about my view that the company was overvalued given the most recent phase ...
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Can the Newly Discovered Obesity Genes Help You Lose Weight?
Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories.
Arena Pharmaceuticals, Inc. (ARNA): Nothing to See Here, No Huge Sales Yet
The sales come from less than a month on the market -- the drug launched on June 11 and the quarter closed on June 30 -- and can't tell you anything about the long-term potential...
Will Arena Pharmaceuticals, Inc. (ARNA) Earnings Finally Explode Higher?
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): How You Should Play These Weight-Loss Drug Companies
The two weight-loss drug approvals in 2012 were the first in more than a decade. The excitement surrounding Arena Pharmaceuticals, Inc.
VIVUS, Inc. (VVUS), AstraZeneca plc (ADR) (AZN): Great Job, Now You’re Fired
"As a founding CEO, over the past 22 years, Leland has secured four drug approvals, an unheard-of achievement for a small pharmaceutical company. He has taken VIVUS, Inc.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): One Weight-Loss Drug That Investors Forgot
You know Belviq and Qsymia and Contrave and Empatic, but do you recall the still most widely used weight-loss drug of all? It seems almost like ancient history now, but back in...
VIVUS, Inc. (VVUS): Obesity Drug Finally Hits Pharmacies
After gaining Food and Drug Administration approval nearly a year ago, patients can finally walk into a pharmacy and get their prescription for VIVUS, Inc.
VIVUS, Inc. (VVUS): Qsymia Just Won The Lotto
After almost a decade, the FDA has once again started approving obesity drugs. VIVUS, Inc. (NASDAQ:VVUS)’s Qysmia and Arena Pharmaceuticals, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Weight Loss Drug Sweepstakes
First investors were reminded of the struggle between VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Orexigen Therapeutics, Inc.
Arena Pharmaceuticals, Inc. (ARNA) News: Positive Rating, Anti-Obesity Drug, Post-Launch Presentation & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Orexigen Therapeutics, Inc.
Abbott Laboratories (ABT), VIVUS, Inc. (VVUS) – It’s Official: Obesity Is a Disease
The decision wasn't without debate, though. In fact, the AMA's Council on Science and Public Health actually recommended against calling obesity a disease.
MannKind Corporation (MNKD), Orexigen Therapeutics, Inc. (OREX): Two Biotech Approval Outcomes That Might Affect You
An FDA approval is the Holy Grail for biotechnology companies and their investors – but a successful launch is the most momentous in producing long-term gains.
Hedge Funds Are Crazy About Dynavax Technologies Corporation (DVAX)
To the average investor, there are dozens of gauges shareholders can use to track publicly traded companies.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): New Obesity Drug Hits the Market
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)' Belviq, the newest offering, looks relatively safe.
Orexigen Therapeutics, Inc. (OREX): Are Hedge Funds Right About This Stock?
To the average investor, there are plenty of methods shareholders can use to monitor their holdings. A pair of the most useful are hedge fund and insider trading interest.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): This Obesity Drugmaker Is Badly In Need of a Marketing Partner
As recently as a decade ago, the biggest hurdle for biotech companies wasn't competition from their peers or even the sale price of their drugs.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) Are NOT The Newest Obesity Drug Player
VIVUS, Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals, Inc.
Amarin Corporation plc (ADR) (AMRN): What’s The Smart Money Think?
Amarin Corporation plc (ADR) (NASDAQ:AMRN) was in 19 hedge funds' portfolio at the end of March.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Why This Obesity Drug Is the Sector’s Best Bet
Editor's Note: The original article incorrectly stated Schedule IV drugs are the second-most-restrictive.
Arena Pharmaceuticals, Inc. (ARNA): Why This Obesity Drug Is the Sector’s Best Bet
The obesity drug space is becoming increasingly complex and hard to predict. After months of waiting patiently, Arena Pharmaceuticals, Inc.
Orexigen Therapeutics, Inc. (OREX), And Three Pipeline Obesity Treatments You Should Watch
Obesity is a growing pandemic for many industrialized nations, especially in the U.S., where it now affects almost 36% of adults and 17% of adolescents.
Whole Foods Market (WFM), Chipotle Mexican Grill, Inc. (CMG): The 9 Most Obese Countries in the World
The rate of worldwide obesity has been marching higher at an extraordinary rate for more than three decades now.
Arena Pharmaceuticals, Inc. (ARNA), Vivus, Inc. (VVUS) & Orexigen Therapeutics, Inc. (OREX): What’s Weight Loss For Now?
It wasn't that long ago that obesity drugs were considered a lifestyle drug. Doctors, the Food and Drug Administration, and insurers believed losing weight was a vanity issue.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): A Belviq Battle
Things are beginning to look slightly up for obesity drugmaker VIVUS, Inc. (NASDAQ:VVUS) -- mere weeks before a competing drug from Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (ARNA): You Need To See These 5 Points
A sharp drop in Arena Pharmaceuticals (NASDAQ:ARNA) followed after the company reported quarterly earnings and a withdrawal of its Marketing Authorization Application (“MAA”) ...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) & Orexigen Therapeutics, Inc. (OREX): The Bottom Line
VIVUS, Inc. (NASDAQ:VVUS)' Qsymia has not received the unconditional consumer love that investors were hoping.
